Immune Checkpoint Inhibitors Related to Cardiotoxicity

Immune checkpoint inhibitors (ICIs) have now emerged as a mainstay of treatment for various cancers. Along with development of ICIs, immune-related adverse effects (irAEs) have aroused wide attention. The cardiac irAE, one of the rare but potentially fatal effects, have been reported recently. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ru, Zhou, Min, Zhu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697232/
https://www.ncbi.nlm.nih.gov/pubmed/36354777
http://dx.doi.org/10.3390/jcdd9110378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697232/
https://www.ncbi.nlm.nih.gov/pubmed/36354777
http://dx.doi.org/10.3390/jcdd9110378

Ejemplares similares